Financhill
Sell
23

HOWL Quote, Financials, Valuation and Earnings

Last price:
$1.00
Seasonality move :
29.54%
Day range:
$0.94 - $1.00
52-week range:
$0.60 - $2.38
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
52.13x
P/B ratio:
1.56x
Volume:
305.6K
Avg. volume:
663.7K
1-year change:
-46.23%
Market cap:
$46.2M
Revenue:
$1.9M
EPS (TTM):
-$1.62

Earnings Data

Next earnings date for HOWL
Mar 10
2026
Most recent earnings per share
-$0.36
Beat by $0.03
(Nov 4/2025)
Consensus Estimate
-$0.38
(Nov 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HOWL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/10/2026 Q4 -- -- -- -$0.36 --
11/04/2025 Q3 -- -- -$0.36 -$0.38 $0.03
08/14/2025 Q2 -- -- -$0.40 -$0.37 -$0.03
05/09/2025 Q1 $300K -- -$0.40 -$0.43 $0.03
03/11/2025 Q4 $301.6K -- -$0.46 -$0.31 -$0.15
11/07/2024 Q3 $709.3K -- -$0.38 -$0.39 $0.01
08/08/2024 Q2 $841.8K $1.1M -$0.43 -$0.39 -$0.04
05/03/2024 Q1 $1.5M $742K -$0.39 -$0.34 -$0.05
03/07/2024 Q4 $1.9M $1.5M -$0.33 -$0.41 $0.08
11/14/2023 Q3 -- -- -$0.23 -$0.35 $0.12
08/10/2023 Q2 -- -- -$0.14 -$0.40 $0.26
05/11/2023 Q1 -- -- -$0.34 -$0.46 $0.12
03/23/2023 Q4 -- -- -$0.39 -$0.51 $0.12
11/10/2022 Q3 -- -- -$0.40 -$0.56 $0.16
08/11/2022 Q2 -- -- -$0.53 -$0.60 $0.07
05/10/2022 Q1 -- -- -$0.56 -$0.58 $0.02
03/24/2022 Q4 -- -- -$0.66 -$0.53 -$0.13
11/10/2021 Q3 -- -- -$0.51 -$0.46 -$0.05
08/12/2021 Q2 -- -- -$3.82 -$0.28 -$3.54
06/10/2021 Q1 -- -- -$3.90 -$0.43 -$3.47
12/31/2020 Q4 -- -- -$0.82 -- --
03/31/2020 Q1 -- -- -$0.43 -- --

Werewolf Therapeutics, Inc. Earnings Questions

  • How Much did Werewolf Therapeutics, Inc. Generate in Revenue Last Quarter?

    Werewolf Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Werewolf Therapeutics, Inc. Beat Earnings Last Quarter?

    Werewolf Therapeutics, Inc. announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.38 per share.

  • Is Werewolf Therapeutics, Inc. Profitable?

    Werewolf Therapeutics, Inc. reported -$402K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Werewolf Therapeutics, Inc. EPS Next Year?

    Werewolf Therapeutics, Inc.'s earnings are forecast to decrease from -$1.63 per share to -$1.42 per share next year representing a decrease of -9.4%.

  • When is Werewolf Therapeutics, Inc.'s Earnings Date?

    Werewolf Therapeutics, Inc.'s next earnings date is March 10, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
50
TGL alert for Dec 8

Treasure Global, Inc. [TGL] is up 29.72% over the past day.

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 46.38% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock